NOVEL ANTI-MALIGNANT TUMOR AGENT
| 外国特許コード | F130007616 |
|---|---|
| 整理番号 | S2012-0313-N0 |
| 掲載日 | 2013年8月16日 |
| 出願国 | 世界知的所有権機関（ＷＩＰＯ） |
| 国際出願番号 | 2013JP051275 |
| 国際公開番号 | WO 2013/111770 |
| 国際出願日 | 平成25年1月23日(2013.1.23) |
| 国際公開日 | 平成25年8月1日(2013.8.1) |
| 優先権データ |
|
| 発明の名称 （英語） | NOVEL ANTI-MALIGNANT TUMOR AGENT |
| 発明の概要（英語） |
The present invention provides an anti-tumor agent which is a molecular targeted drug for a malignant tumor and is highly safe. An anti-malignant tumor agent characterized by comprising, as an active ingredient, a substance capable of targeting a ribosome protein of which the expression is increased in a malignant tumor cell. The substance capable of targeting a ribosome protein of which the expression is increased in a malignant tumor cell according to the present invention is considered as a substance involved in a biological defense mechanism that is believed to be provided intrinsically in a living body and can prevent the development of diseases even if a cancer cell is generated. Specifically, the ribosome protein of which the expression is increased is RPL29 and/or RPS4X. A substance capable of targeting RPL29 and/or RPS4X is an anti-RPL29 antibody and/or an anti-RPS4X antibody, a substance capable of activating or enhancing an endogenous anti-RPL29 antibody and/or an endogenous anti-RPS4X antibody occurring in a living body, a substance capable of inducing the production of an anti-RPL29 antibody and/or an anti-RPS4X antibody in a living body, or an antagonist of RPL29 and/or RPS4X. The present invention also provides a method for testing an malignant tumor, in which an anti-RPL29 antibody titer and/or an anti-RPS4X antibody titer is employed as a measure. |
|
|
|
|
| 国際特許分類(IPC) |
|
日本語項目の表示
| 発明の名称 | 新規抗悪性腫瘍剤 |
|---|
『 NOVEL ANTI-MALIGNANT TUMOR AGENT 』に関するお問合せ
- 国立大学法人 岡山大学 知的財産本部
- URL: http://www.orpc.okayama-u.ac.jp/kikou/chizai_01.html
-
E-mail:
- Address: 〒700-8530 岡山県岡山市北区津島中１－１－１
- TEL: 086-251-8472
- FAX: 086-251-8961
※ 同じキーワードでJ-STORE内を検索することが出来ます。→ J-STORE内を検索
